Geoffrey C. Farrell

34.0k total citations · 11 hit papers
213 papers, 26.1k citations indexed

About

Geoffrey C. Farrell is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Geoffrey C. Farrell has authored 213 papers receiving a total of 26.1k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Epidemiology, 98 papers in Hepatology and 48 papers in Pharmacology. Recurrent topics in Geoffrey C. Farrell's work include Liver Disease Diagnosis and Treatment (126 papers), Hepatitis C virus research (43 papers) and Liver Disease and Transplantation (36 papers). Geoffrey C. Farrell is often cited by papers focused on Liver Disease Diagnosis and Treatment (126 papers), Hepatitis C virus research (43 papers) and Liver Disease and Transplantation (36 papers). Geoffrey C. Farrell collaborates with scholars based in Australia, United States and Brazil. Geoffrey C. Farrell's co-authors include Claire Z. Larter, Shivakumar Chitturi, Jacob George, Isabelle Leclercq, Narci Teoh, Jason M. Hui, James G. Kench, Graham Robertson, Christopher Liddle and Matthew M. Yeh and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Geoffrey C. Farrell

213 papers receiving 25.4k citations

Hit Papers

The NAFLD fibrosis score 1998 2026 2007 2016 2007 2006 2004 2002 2017 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The NAFLD fibrosis score
    2007 2.3k citations Jason M. Hui, Jacob George et al. Hepatology profile →
  2. Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
    2006 2.0k citations Geoffrey C. Farrell, Claire Z. Larter Hepatology profile →
  3. Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
    2004 1.7k citations Geoffrey C. Farrell et al. profile →
  4. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
    2002 936 citations Shivakumar Chitturi, Shehan Abeygunasekera et al. Hepatology profile →
  5. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
    2017 863 citations Auvro R. Mridha, Alexander Wree et al. Journal of Hepatology profile →
  6. Beyond insulin resistance in NASH: TNF-α or adiponectin?
    2004 792 citations Jason M. Hui, Geoffrey C. Farrell et al. Hepatology profile →
  7. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
    2000 636 citations Isabelle Leclercq, Geoffrey C. Farrell et al. profile →
  8. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
    2003 582 citations Jason M. Hui, Geoffrey C. Farrell et al. Gastroenterology profile →
  9. Etiopathogenesis of Nonalcoholic Steatohepatitis
    2001 536 citations Shivakumar Chitturi, Geoffrey C. Farrell profile →
  10. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
    1998 503 citations Martin Weltman, Geoffrey C. Farrell et al. Hepatology profile →
  11. NAFLD in Asia—as common and important as in the West
    2013 364 citations Geoffrey C. Farrell, Vincent Wai‐Sun Wong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey C. Farrell Australia 76 19.9k 10.0k 6.9k 4.7k 3.7k 213 26.1k
Christopher P. Day United Kingdom 86 23.0k 1.2× 10.2k 1.0× 9.9k 1.4× 4.1k 0.9× 3.7k 1.0× 186 31.1k
Brent A. Neuschwander‐Tetri United States 67 25.1k 1.3× 10.2k 1.0× 11.3k 1.6× 5.6k 1.2× 5.0k 1.4× 188 30.8k
Kris V. Kowdley United States 86 20.1k 1.0× 14.5k 1.4× 5.1k 0.7× 3.2k 0.7× 5.6k 1.5× 451 29.4k
Ariel E. Feldstein United States 77 17.2k 0.9× 6.3k 0.6× 6.7k 1.0× 9.2k 2.0× 3.8k 1.0× 220 26.9k
Paul Angulo United States 72 22.1k 1.1× 11.8k 1.2× 9.3k 1.3× 2.7k 0.6× 5.9k 1.6× 155 26.6k
Joel E. Lavine United States 60 24.3k 1.2× 9.8k 1.0× 11.8k 1.7× 3.4k 0.7× 4.8k 1.3× 144 28.4k
Arthur J. McCullough United States 73 28.2k 1.4× 12.0k 1.2× 12.0k 1.7× 5.5k 1.2× 6.0k 1.6× 293 35.4k
Michael Charlton United States 69 19.5k 1.0× 12.9k 1.3× 6.2k 0.9× 3.1k 0.7× 5.4k 1.4× 250 25.3k
Mary E. Rinella United States 50 18.5k 0.9× 7.4k 0.7× 7.7k 1.1× 4.0k 0.8× 3.2k 0.9× 133 21.5k
Leon A. Adams Australia 62 18.9k 1.0× 9.1k 0.9× 7.9k 1.1× 2.9k 0.6× 3.1k 0.8× 202 22.9k

Countries citing papers authored by Geoffrey C. Farrell

Since Specialization
Citations

This map shows the geographic impact of Geoffrey C. Farrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey C. Farrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey C. Farrell more than expected).

Fields of papers citing papers by Geoffrey C. Farrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey C. Farrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey C. Farrell. The network helps show where Geoffrey C. Farrell may publish in the future.

Co-authorship network of co-authors of Geoffrey C. Farrell

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey C. Farrell. A scholar is included among the top collaborators of Geoffrey C. Farrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey C. Farrell. Geoffrey C. Farrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farrell, Geoffrey C., Fahrettin Haczeyni, & Shivakumar Chitturi. (2018). Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease. Advances in experimental medicine and biology. 1061. 19–44. 130 indexed citations
2.
Thompson, Richard J., Kate D. Williamson, John Bate, et al.. (2018). Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications. Journal of Gastroenterology and Hepatology. 34(2). 425–435. 7 indexed citations
3.
Mridha, Auvro R., Alexander Wree, Avril A. B. Robertson, et al.. (2017). NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Journal of Hepatology. 66(5). 1037–1046. 863 indexed citations breakdown →
4.
Wong, Vincent Wai‐Sun, Shivakumar Chitturi, Grace Lai–Hung Wong, et al.. (2016). Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. ˜The œLancet. Gastroenterology & hepatology. 1(1). 56–67. 130 indexed citations
5.
Legry, Vanessa, et al.. (2014). Role of ciliary dysfunction in a new model of obesity and non-alcoholic steatohepatitis: the foz/fozmice. Archives of Public Health. 72(S1). 8 indexed citations
6.
Farrell, Geoffrey C., et al.. (2012). NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut and Liver. 6(2). 149–171. 319 indexed citations
7.
Larter, Claire Z., et al.. (2011). Peroxisome proliferator‐activated receptor‐α agonist, Wy 14 643, improves metabolic indices, steatosis and ballooning in diabetic mice with non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology. 27(2). 341–350. 80 indexed citations
8.
George, Alexis, Adrian Bauman, Amanda Johnston, et al.. (2009). Independent effects of physical activity in patients with nonalcoholic fatty liver disease #. Hepatology. 50(1). 68–76. 250 indexed citations
9.
Farrell, Geoffrey C.. (2005). Signalling links in the liver: Knitting SOCS with fat and inflammation. Journal of Hepatology. 43(1). 193–196. 42 indexed citations
10.
Bandara, Priyanka, Jacob George, Geoffrey W. McCaughan, et al.. (2005). Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C. Liver International. 25(3). 518–526. 12 indexed citations
11.
Larter, Claire Z. & Geoffrey C. Farrell. (2005). Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?. Journal of Hepatology. 44(2). 253–261. 120 indexed citations
12.
Teoh, Narci & Geoffrey C. Farrell. (2003). Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clinics in Liver Disease. 7(2). 401–413. 55 indexed citations
13.
Chitturi, Shivakumar, Shehan Abeygunasekera, Geoffrey C. Farrell, et al.. (2002). NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 35(2). 373–379. 936 indexed citations breakdown →
14.
Farrell, Geoffrey C.. (2000). Hepatitis B e antigen seroconversion: Effects of lamivudine alone or in combination with interferon alpha. Journal of Medical Virology. 61(3). 374–379. 22 indexed citations
15.
Enriquez, Annabelle, Isabelle Leclercq, Geoffrey C. Farrell, & Graham Robertson. (1999). Altered Expression of HepaticCYP2E1andCYP4Ain Obese, Diabeticob/obMice, andfa/faZucker Rats. Biochemical and Biophysical Research Communications. 255(2). 300–306. 97 indexed citations
16.
Zhang, Baohong & Geoffrey C. Farrell. (1999). Chronic Ethanol Consumption Disrupts Complexation between EGF Receptor and Phospholipase C-γ1: Relevance to Impaired Hepatocyte Proliferation. Biochemical and Biophysical Research Communications. 257(1). 89–94. 26 indexed citations
17.
Robertson, Graham, Geoffrey C. Farrell, & Christopher Liddle. (1998). Sexually Dimorphic Expression of Rat CYP3A9 and CYP3A18 Genes Is Regulated by Growth Hormone. Biochemical and Biophysical Research Communications. 242(1). 57–60. 49 indexed citations
18.
Farrell, Geoffrey C.. (1996). Career paths for clinical scientists. Journal of Gastroenterology and Hepatology. 11(9). 891–894. 2 indexed citations
19.
Liddle, Christopher, Michael T. Murray, & Geoffrey C. Farrell. (1989). Effect of Liver Regeneration on Hepatic Cytochrome P450 Isozymes and Serum Sex Steroids in the Male Rat. Gastroenterology. 96(2). 864–872. 36 indexed citations
20.
Farrell, Geoffrey C., Rudi Schmid, Kent L. Kunze, & Paul R. Ortiz de Montellano. (1979). Exogenous heme restores in vivo functional capacity of hepatic cytochrome P-450 destroyed by allylisopropylacetamide. Biochemical and Biophysical Research Communications. 89(2). 456–463. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher P. Day Breakdown of academic impact, for papers by Brent A. Neuschwander‐Tetri Breakdown of academic impact, for papers by Kris V. Kowdley Breakdown of academic impact, for papers by Ariel E. Feldstein Breakdown of academic impact, for papers by Paul Angulo Breakdown of academic impact, for papers by Joel E. Lavine Breakdown of academic impact, for papers by Arthur J. McCullough Breakdown of academic impact, for papers by Michael Charlton Breakdown of academic impact, for papers by Mary E. Rinella Breakdown of academic impact, for papers by Leon A. Adams
Rankless by CCL
2026